Learnings from a roundtable discussion with Medical Affairs leadership from 11 pharma companies
Dr. Deepak Patil
Advertisement
Articles by Dr. Deepak Patil
Global medical affairs teams seek better support to manage relationships with key opinion leaders—and find that balance between patient needs, scientific objectives, and the interest areas of KOLs.
Top industry experts weigh in on what the new year holds for the pharma industry.
Advertisement
Latest Updated Articles
Advertisement
Advertisement
Trending on PharmExec
1
Novo Nordisk’s Unsolicited Proposal to Acquire Metsera
2
Tylenol Maker Sued While Kennedy Says No ‘Sufficient’ Evidence for Autism Link
3
AI Built for Pharma—Out-of-the-Box Wins on Time, Risk, and ROI
4
Investors Have Questions About GLP-1 Drug Prices Ahead of Eli Lilly and Novo Quarterly Statements: Report
5
